跳至主要内容
临床试验/NCT02180074
NCT02180074已完成不适用

Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease

Louisiana State University Health Sciences Center Shreveport1 个研究点 分布在 1 个国家目标入组 137 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
137
试验地点
1
主要终点
Free Sulfide, Bound Sulfide and Acid Labile Sulfide

研究概览

简要总结

Cardiovascular disease which includes coronary artery disease and peripheral artery disease remains the leading cause of death among women in the United States. The impact of cardiovascular in women was not recognized by clinicians for a long time. It is now evident that, women suffer the consequences of cardiovascular at rates at least as high as those observed in men but there are still major gaps in our understanding this disease in women. Hydrogen sulfide (H2S), a gaseous mediator plays an important role in the cardiovascular system. Research has demonstrated it's critical role in animal ischemia reperfusion models. Hydrogen sulfide exists in distinct biological pools in blood. Recently, the Kevil lab has pioneered the development of new analytical techniques for accurate measurement of all biological pools of H2S. By measuring these distinct pools of H2S in women with and without cardiovascular disease the investigators hope to further understanding of role of H2S in pathophysiology of cardiovascular disease. This research will help to assess the ability of H2S and its distinct biological pools to potentially be a diagnostic marker or a therapeutic target for cardiovascular disease.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients presenting to the cardiac catheterization laboratory for coronary or peripheral angiography.
  • Females,Age>40years

排除标准

  • Inability to provide informed consent.
  • STelevationmyocardialinfarction.
  • Cardiogenicshock.
  • ABI >1.4 (indicative of non-compressible vessel needing further evaluation to diagnose PAD), unless documented known PAD.
  • Non-atheroscleroticPAD(e.g.Buerger'sdisease).
  • Enrolment in another clinical trial with use of experimental therapeutic agents.

结局指标

主要结局

Free Sulfide, Bound Sulfide and Acid Labile Sulfide

时间窗: 1 year

Unit of Measure: nMol

次要结局

未报告次要终点

研究者

发起方
Louisiana State University Health Sciences Center Shreveport
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Kevil

Professor

Louisiana State University Health Sciences Center Shreveport

研究点 (1)

Loading locations...

相似试验